CD274 and neoplasm: Tumor-infiltrating B cell frequency not only predicts better survival in patients with lung cancer, but also therapeutic response, including PD-1/PD-L1 immune checkpoint blockade (37–39), which is in part explained by higher PD-L1 expression level in B cell-enriched tumors (40).